Insulet EBITDA Margin 2010-2025 | PODD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Insulet (PODD) over the last 10 years. The current EBITDA margin for Insulet as of June 30, 2025 is .
Insulet EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-06-30 $2.36B $0.49B 20.93%
2025-03-31 $2.20B $0.43B 19.32%
2024-12-31 $2.07B $0.39B 18.81%
2024-09-30 $1.99B $0.38B 19.35%
2024-06-30 $1.87B $0.35B 18.62%
2024-03-31 $1.78B $0.32B 18.18%
2023-12-31 $1.70B $0.29B 17.26%
2023-09-30 $1.56B $0.21B 13.35%
2023-06-30 $1.47B $0.15B 10.44%
2023-03-31 $1.37B $0.09B 6.80%
2022-12-31 $1.31B $0.10B 7.74%
2022-09-30 $1.24B $0.13B 10.14%
2022-06-30 $1.18B $0.16B 13.16%
2022-03-31 $1.14B $0.21B 18.21%
2021-12-31 $1.10B $0.18B 16.74%
2021-09-30 $1.04B $0.14B 13.21%
2021-06-30 $1.00B $0.12B 12.46%
2021-03-31 $0.96B $0.12B 12.42%
2020-12-31 $0.90B $0.11B 11.73%
2020-09-30 $0.87B $0.12B 13.26%
2020-06-30 $0.83B $0.11B 12.73%
2020-03-31 $0.78B $0.08B 10.57%
2019-12-31 $0.74B $0.08B 10.57%
2019-09-30 $0.69B $0.07B 10.37%
2019-06-30 $0.65B $0.06B 8.88%
2019-03-31 $0.60B $0.05B 8.67%
2018-12-31 $0.56B $0.04B 7.80%
2018-09-30 $0.53B $0.03B 4.91%
2018-06-30 $0.50B $0.02B 4.19%
2018-03-31 $0.49B $0.01B 2.67%
2017-12-31 $0.47B $0.01B 1.51%
2017-09-30 $0.44B $0.00B 0.68%
2017-06-30 $0.41B $0.00B 0.73%
2017-03-31 $0.39B $0.01B 1.29%
2016-12-31 $0.37B $0.00B 0.82%
2016-09-30 $0.35B $0.00B -1.15%
2016-06-30 $0.32B $-0.02B -6.50%
2016-03-31 $0.30B $-0.03B -11.11%
2015-12-31 $0.26B $-0.03B -12.50%
2015-09-30 $0.20B $-0.02B -10.77%
2015-06-30 $0.20B $-0.01B -5.03%
2015-03-31 $0.21B $0.00B -0.95%
2014-12-31 $0.23B $0.00B 1.30%
2014-09-30 $0.29B $0.00B 0.70%
2014-06-30 $0.27B $-0.01B -4.43%
2014-03-31 $0.26B $-0.01B -5.02%
2013-12-31 $0.25B $-0.02B -6.88%
2013-09-30 $0.24B $-0.02B -9.75%
2013-06-30 $0.23B $-0.02B -6.52%
2013-03-31 $0.22B $-0.02B -9.05%
2012-12-31 $0.21B $-0.03B -11.79%
2012-09-30 $0.20B $-0.03B -14.93%
2012-06-30 $0.19B $-0.03B -16.23%
2012-03-31 $0.17B $-0.04B -20.93%
2011-12-31 $0.15B $-0.03B -22.37%
2011-09-30 $0.13B $-0.04B -30.08%
2011-06-30 $0.11B $-0.04B -33.63%
2011-03-31 $0.10B $-0.03B -30.77%
2010-12-31 $0.10B $-0.03B -35.05%
2010-09-30 $0.09B $-0.03B -32.58%
2010-06-30 $0.08B $-0.04B -42.17%
2010-03-31 $0.08B $-0.04B -54.67%
2009-12-31 $0.07B $-0.05B -72.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.358B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.027B 26.85
Boston Scientific (BSX) United States $157.644B 37.59
Stryker (SYK) United States $150.755B 30.69
EssilorLuxottica (ESLOY) France $144.001B 0.00
Medtronic (MDT) Ireland $118.256B 16.67
Lonza Group Ag (LZAGY) Switzerland $50.628B 0.00
Haleon (HLN) United Kingdom $43.188B 24.69
ResMed (RMD) United States $41.753B 29.86
GE HealthCare Technologies (GEHC) United States $33.827B 15.90
Agilent Technologies (A) United States $33.605B 21.91
Koninklijke Philips (PHG) Netherlands $26.779B 17.71
Terumo (TRUMY) Japan $26.532B 31.44
Zimmer Biomet Holdings (ZBH) United States $21.303B 13.56
Smith & Nephew SNATS (SNN) United Kingdom $16.337B 0.00
Baxter (BAX) United States $12.584B 9.72
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.027B 29.48
Lantheus Holdings (LNTH) United States $3.785B 10.23
Envista Holdings (NVST) United States $3.513B 24.58
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.268B 14.50
Perrigo (PRGO) Ireland $3.265B 8.15
ICU Medical (ICUI) United States $3.109B 21.17
Haemonetics (HAE) United States $2.661B 11.88
LeMaitre Vascular (LMAT) United States $2.157B 46.25
Acuren (TIC) United States $2.156B 0.00
Curaleaf Holdings (CURLF) Canada $2.117B 0.00
QuidelOrtho (QDEL) United States $1.896B 11.93
Green Thumb Industries (GTBIF) United States $1.888B 81.09
AtriCure (ATRC) United States $1.882B 0.00
Tilray Brands (TLRY) Canada $1.596B 0.00
Phibro Animal Health (PAHC) United States $1.323B 16.91
AdaptHealth (AHCO) United States $1.246B 17.71
BioLife Solutions (BLFS) United States $1.229B 2565.00
Neogen (NEOG) United States $1.223B 19.41
Kestra Medical Technologies (KMTS) United States $0.952B 0.00
InMode (INMD) Israel $0.941B 8.70
Valneva SE (VALN) France $0.762B 0.00
Cresco Labs (CRLBF) United States $0.683B 0.00
SNDL (SNDL) Canada $0.649B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.618B 0.00
Verano Holdings (VRNOF) United States $0.615B 0.00
ZimVie (ZIMV) United States $0.535B 20.62
Surmodics (SRDX) United States $0.496B 0.00
Evolus (EOLS) United States $0.495B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.11
CeriBell (CBLL) United States $0.420B 0.00
Owens & Minor (OMI) United States $0.387B 3.43
Sanuwave Health (SNWV) United States $0.360B 0.00
Canopy Growth (CGC) Canada $0.353B 0.00
TerrAscend (TSNDF) Canada $0.352B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Brainsway (BWAY) Israel $0.301B 61.15
Sanara MedTech (SMTI) United States $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.299B 0.00
Omeros (OMER) United States $0.298B 0.00
Capricor Therapeutics (CAPR) United States $0.296B 0.00
High Tide (HITI) Canada $0.283B 0.00
Viemed Healthcare (VMD) United States $0.273B 20.74
Cerus (CERS) United States $0.255B 0.00
OraSure Technologies (OSUR) United States $0.255B 0.00
TriSalus Life Sciences (TLSI) United States $0.254B 0.00
Vireo Growth (VREOF) United States $0.241B 0.00
Organigram Global (OGI) Canada $0.221B 0.00
Quanterix (QTRX) United States $0.218B 0.00
Exagen (XGN) United States $0.218B 0.00
Utah Medical Products (UTMD) United States $0.195B 16.24
FitLife Brands (FTLF) United States $0.173B 21.31
Biote (BTMD) United States $0.164B 5.43
Jushi Holdings (JUSHF) United States $0.151B 0.00
Jin Medical (ZJYL) China $0.130B 0.00
MacroGenics (MGNX) United States $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 12.32
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.068B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 32.90
Veru (VERU) United States $0.051B 0.00
Zynex (ZYXI) United States $0.050B 0.00
Nephros (NEPH) United States $0.043B 33.67
Rockwell Medical (RMTI) United States $0.043B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 14.62
Trinity Biotech (TRIB) Ireland $0.027B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Sharps Technology (STSS) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00